ABSI
Price
$9.55
Change
+$0.27 (+2.91%)
Updated
Aug 21 closing price
Capitalization
1.64B
88 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$3.91
Change
+$0.17 (+4.55%)
Updated
Aug 21 closing price
Capitalization
1.17B
75 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs SANA

ABSI vs SANA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABSI vs. SANA commentary
Aug 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and SANA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 22, 2026
Stock price -- (ABSI: $9.28 vs. SANA: $3.74)
Brand notoriety: ABSI and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 45% vs. SANA: 80%
Market capitalization -- ABSI: $1.64B vs. SANA: $1.17B
ABSI [@Biotechnology] is valued at $1.64B. SANA’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 6 TA indicator(s) are bullish while SANA’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 6 bullish, 3 bearish.
  • SANA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABSI is a better buy in the short-term than SANA.

Price Growth

ABSI (@Biotechnology) experienced а -1.90% price change this week, while SANA (@Biotechnology) price change was +1.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 17, 2026.

SANA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($1.64B) has a higher market cap than SANA($1.17B). ABSI YTD gains are higher at: 186.246 vs. SANA (0.737). ABSI has higher annual earnings (EBITDA): -106.8M vs. SANA (-192.2M). ABSI has more cash in the bank: 126M vs. SANA (101M). ABSI has less debt than SANA: ABSI (4.42M) vs SANA (75.3M). ABSI has higher revenues than SANA: ABSI (1.84M) vs SANA (0).
ABSISANAABSI / SANA
Capitalization1.64B1.17B140%
EBITDA-106.8M-192.2M56%
Gain YTD186.2460.73725,268%
P/E RatioN/AN/A-
Revenue1.84M0-
Total Cash126M101M125%
Total Debt4.42M75.3M6%
TECHNICAL ANALYSIS
Technical Analysis
ABSISANA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
90%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TNXT28.610.35
+1.22%
T. Rowe Price Innovation Leaders ETF
DDSQ21.470.05
+0.23%
Innovator Equity Dual Dir 5 Buf ETF
JXI83.04-0.01
-0.01%
iShares Global Utilities ETF
NBXG15.20-0.27
-1.75%
Neuberger Next Generation Connectivity Fund Inc.
BTCZ4.72-0.64
-11.94%
T-Rex 2X Inverse Bitcoin Daily Target ETF

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+12.88%
RXRX - ABSI
60%
Loosely correlated
+13.27%
CRSP - ABSI
58%
Loosely correlated
+12.91%
SANA - ABSI
56%
Loosely correlated
+12.95%
ABCL - ABSI
55%
Loosely correlated
+8.00%
BEAM - ABSI
51%
Loosely correlated
+9.41%
More